We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
(+6.5%)
Cap. Flow
+$92.3M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$905M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$585M |
| 3 |
Cisco
CSCO
|
+$554M |
| 4 |
International Flavors & Fragrances
IFF
|
+$456M |
| 5 |
Mastercard
MA
|
+$392M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
DuPont de Nemours
DD
|
+$556M |
| 3 |
Qualcomm
QCOM
|
+$405M |
| 4 |
Merck
MRK
|
+$333M |
| 5 |
TSMC
TSM
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.54% |
| 5 | Communication Services | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBIO
2326
DELISTED
Generation Bio
GBIO
| $3.36M | ﹤0.01% |
11,812
+7,151
| +153% | +$2.29M |
|
2327
Heritage Insurance Holdings
HRTG
$991M
| $3.36M | ﹤0.01% |
303,103
+3,316
| +1% | +$34.6K |
|
|
CAI
2328
DELISTED
CAI International, Inc.
CAI
| $3.35M | ﹤0.01% |
73,710
+2,771
| +4% | +$109K |
|
|
CIVI
2329
DELISTED
Civitas Resources
CIVI
| $3.35M | ﹤0.01% |
93,760
-1,432
| -2% | -$40.4K |
|
|
CCRN
2330
DELISTED
Cross Country Healthcare
CCRN
| $3.33M | ﹤0.01% |
266,727
+68,400
| +34% | +$725K |
|
|
TAST
2331
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $3.33M | ﹤0.01% |
556,049
-12,610
| -2% | -$82.2K |
|
|
SY
2332
So-Young International
SY
$219M
| $3.32M | ﹤0.01% |
336,406
+318,706
| +1,801% | +$4.01M |
|
|
CCF
2333
DELISTED
Chase Corporation
CCF
| $3.32M | ﹤0.01% |
28,523
-209
| -0.7% | -$23.3K |
|
|
SRDX
2334
DELISTED
Surmodics
SRDX
| $3.32M | ﹤0.01% |
59,154
+1,210
| +2% | +$60.3K |
|
|
TRHC
2335
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $3.31M | ﹤0.01% |
71,918
+1,181
| +2% | +$56.4K |
|
2336
Academy Sports + Outdoors
ASO
$2.98B
| $3.31M | ﹤0.01% |
122,602
+70,882
| +137% | +$1.69M |
|
2337
Replimune Group
REPL
$1.01B
| $3.3M | ﹤0.01% |
108,300
-16,121
| -13% | -$604K |
|
|
MCFE
2338
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $3.29M | ﹤0.01% |
144,466
-1,641
| -1% | -$34.1K |
|
|
EGIO
2339
DELISTED
Edgio, Inc. Common Stock
EGIO
| $3.28M | ﹤0.01% |
22,984
-16,833
| -42% | -$2.63M |
|
2340
Artivion
AORT
$1.32B
| $3.28M | ﹤0.01% |
145,132
-66,635
| -31% | -$1.63M |
|
2341
Lennar Class B
LEN.B
$20.8B
| $3.27M | ﹤0.01% |
41,790
-2,275
| -5% | -$152K |
|
|
FBMS
2342
DELISTED
The First Bancshares, Inc.
FBMS
| $3.27M | ﹤0.01% |
89,322
-1,416
| -2% | -$47.5K |
|
2343
Rhythm Pharmaceuticals
RYTM
$7.96B
| $3.26M | ﹤0.01% |
153,269
+18,163
| +13% | +$527K |
|
2344
Manitowoc
MTW
$675M
| $3.26M | ﹤0.01% |
158,061
-257
| -0.2% | -$4.25K |
|
2345
Luxfer Holdings
LXFR
$458M
| $3.25M | ﹤0.01% |
152,618
+793
| +0.5% | +$14.9K |
|
|
BRG
2346
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $3.23M | ﹤0.01% |
319,724
-13,608
| -4% | -$153K |
|
2347
Arcturus Therapeutics
ARCT
$211M
| $3.23M | ﹤0.01% |
78,266
-17,947
| -19% | -$1.07M |
|
|
DCPH
2348
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.22M | ﹤0.01% |
161,564
-19,826
| -11% | -$923K |
|
2349
DraftKings
DKNG
$11.9B
| $3.22M | ﹤0.01% |
52,500
+39,584
| +306% | +$2.38M |
|
2350
Amphastar Pharmaceuticals
AMPH
$916M
| $3.21M | ﹤0.01% |
175,388
-11,172
| -6% | -$208K |
|
Similar funds
VFT
Nuveen's Q1 2021 Portfolio in Review
As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
- Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
- Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
- Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
- Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
- Nuveen opened 118 new positions and closed 82 in Q1 2021.
- Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.
Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.